NOELE THOMPSON: Open Payments
NPI 1255904488 · OAKMONT, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$158 in 8 payments from 6 companies in 2025. Trend: 2023 $779 · 2024 $1,513 · 2025 $158
Food & beverage: $158
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $30 |
| SHIELD THERAPEUTICS INC | 1 | $28 |
| Amgen Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $11 |
Products named: SHINGRIX, CAPLYTA, ACCRUFER, Veozah, OTEZLA, AmBisome, VOQUEZNA.
Industry payments across PA — which companies pay providers there.
